Voyageur Pharmaceuticals Stock Forecast, Price & News

+0.01 (+5.56 %)
(As of 07/30/2021 03:54 PM ET)
Today's Range
50-Day Range
52-Week Range
Volume167,000 shs
Average Volume204,333 shs
Market CapitalizationC$9.57 million
P/E RatioN/A
Dividend YieldN/A
30 days | 90 days | 365 days | Advanced Chart
Receive VM News and Ratings via Email

Sign-up to receive the latest news and ratings for Voyageur Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.

About Voyageur Pharmaceuticals

Voyageur Pharmaceuticals Ltd. focuses on the development of active pharmaceutical ingredients minerals. The company intends to develop barium and iodine radiocontrast products and bromine based pharmaceutical products. It holds 100% interest in three barium sulfate deposits, including two properties suitable in grade for the pharmaceutical barite marketplace located in British Columbia, Canada; and interests in a high-grade iodine, lithium, and bromine brine project in Utah, the United States. The company was formerly known as Voyageur Minerals Ltd. and changed its name to Voyageur Pharmaceuticals Ltd. in December 2019. Voyageur Pharmaceuticals Ltd. is headquartered in Calgary, Canada.


See More Headlines

Industry, Sector and Symbol

Sales & Book Value






Overall MarketRank

1.00 out of 5 stars

Analyst Opinion: 0.0Community Rank: 5.0Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -
speech bubbles
speech bubbles

Voyageur Pharmaceuticals (CVE:VM) Frequently Asked Questions

What stocks does MarketBeat like better than Voyageur Pharmaceuticals?

Wall Street analysts have given Voyageur Pharmaceuticals a "N/A" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Voyageur Pharmaceuticals wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

How has Voyageur Pharmaceuticals' stock been impacted by Coronavirus (COVID-19)?

Voyageur Pharmaceuticals' stock was trading at C$0.07 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization. Since then, VM shares have increased by 46.2% and is now trading at C$0.10.
View which stocks have been most impacted by COVID-19

Who are Voyageur Pharmaceuticals' key executives?

Voyageur Pharmaceuticals' management team includes the following people:
  • Mr. Brent Willis, Pres, CEO & Director (Age 50, Pay $42.5k)
  • Mr. Bradley Craig Willis P.Eng., Founder, COO & Director (Age 50, Pay $42.5k)
  • Mr. Ronald Robert Love, Chief Financial Officer

Who are some of Voyageur Pharmaceuticals' key competitors?

What other stocks do shareholders of Voyageur Pharmaceuticals own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Voyageur Pharmaceuticals investors own include Agile Therapeutics (AGRX), Sierra Oncology (SRRA), Achillion Pharmaceuticals (ACHN), LINE (LN), Littelfuse (LFUS), The Howard Hughes (HHC), EQT (EQT), Deckers Outdoor (DECK), Cranswick (CWK) and Cirrus Logic (CRUS).

What is Voyageur Pharmaceuticals' stock symbol?

Voyageur Pharmaceuticals trades on the Canadian Venture Exchange (CVE) under the ticker symbol "VM."

How do I buy shares of Voyageur Pharmaceuticals?

Shares of VM and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.
Compare Top Brokerages Here.

What is Voyageur Pharmaceuticals' stock price today?

One share of VM stock can currently be purchased for approximately C$0.10.

How much money does Voyageur Pharmaceuticals make?

Voyageur Pharmaceuticals has a market capitalization of C$9.57 million.

What is Voyageur Pharmaceuticals' official website?

The official website for Voyageur Pharmaceuticals is

How can I contact Voyageur Pharmaceuticals?

The company can be reached via phone at 587-779-6166.

This page was last updated on 8/2/2021 by Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.